CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 21.78 Min. order: 1 piece ★★★★★ 4.9 (99 reviews) Sold : Login>>
Dual Therapy CagriSema Promising for Weight and Glycaemic Control US$ 28.54 Min. order: 1 piece ★★★★★ 4.2 (286 reviews) Sold : Login>>
GHK-Cu Therapy: Skin Rejuvenation & Healing US$ 20.30 Min. order: 1 piece ★★★★★ 4.3 (300 reviews) Sold : Login>>
EASD 2025: REDEFINE 2 trial unveils meaningful weight reduction with CagriSema US$ 20.03 Min. order: 1 piece ★★★★★ 4.9 (158 reviews) Sold : Login>>
Anti-obesity Drugs Market Growth Trend Analysis US$ 29.34 Min. order: 1 piece ★★★★★ 4.1 (274 reviews) Sold : Login>>